Metabolic syndrome is a complex of metabolic disorders that increases the risk of developing cardiovascular diseases and type 2 diabetes. It includes insulin resistance, arterial hypertension, dyslipidemia and obesity, especially abdominal obesity. This disease affects the global population and is one of the leading causes of increased morbidity and mortality in the modern world. Metabolic syndrome requires careful attention, since its presence not only worsens the general health, but also significantly reduces the quality of life of patients, bringing many complications to it.
History of the disease and interesting historical facts
Metabolic syndrome, as a clinical concept, was described in the mid-20th century. In 1988, researcher Alfredo O. Heifetz proposed the term "metabolic syndrome" to describe a set of risk factors associated with insulin resistance and an increased likelihood of developing diabetes. In subsequent years, studies were conducted that revealed a link between metabolic syndrome and cardiovascular diseases. An interesting fact is that the understanding of obesity and metabolic disorders has changed in different historical eras. For example, in ancient Greece, excess weight was perceived as a sign of wealth and prosperity, while in modern society it is considered a serious health risk factor.
Epidemiology
According to the World Health Organization (WHO), metabolic syndrome affects more than 20% of the adult population in developed countries. In the last decade, there has been a sharply increasing trend in the spread of this syndrome, which is associated with lifestyle changes, an increase in the number of overweight and sedentary people. Research data show that in some countries in South Asia and Latin America, the incidence reaches 30-40% among the adult population. It is noteworthy that this syndrome is diagnosed even in young people and adolescents, which poses a threat to the health of future generations.
Genetic predisposition to this disease
Genetic predisposition to metabolic syndrome is created by a complex of polygenic factors. Research shows that some mutations in genes responsible for fat and carbohydrate metabolism may be associated with the development of this syndrome. Key genes involved in the pathogenesis of metabolic syndrome are:
- Genes responsible for insulin levels, such as INS and IGF1R.
- Genes that regulate lipid metabolism, such as APOA5 and FTO.
- Genes responsible for inflammatory processes, including IL6 and TNF-α.
Genetic studies show that having metabolic syndrome in one parent significantly increases the risk of it developing in children.
Risk factors for the development of this disease
Metabolic syndrome has many risk factors, both modifiable and non-modifiable. The main risk factors include:
- Obesity, especially abdominal, is considered an important predictor of the development of the syndrome.
- Low physical activity and sedentary lifestyle.
- Poor diet, including high intake of sugar and saturated fat.
- Smoking and alcohol abuse.
- Age and gender: The risk of developing metabolic syndrome increases with age, and it is higher in men than in women.
- Family history of cardiovascular disease and diabetes.
The presence of one or more risk factors requires active monitoring and may predetermine the need for lifestyle changes and medical intervention.
Diagnosis of this disease
Diagnosis of metabolic syndrome is based on clinical manifestations and standard laboratory tests. The main symptoms that may indicate the presence of the syndrome include:
- Excess body weight and waist circumference more than 102 cm in men and more than 88 cm in women.
- High blood pressure - systolic above 130 mmHg or diastolic above 85 mmHg.
- Triglyceride levels are above 1.7 mmol/L.
- HDL (high-density lipoprotein) levels are below 1.0 mmol/L in men and below 1.3 mmol/L in women.
- Impaired fasting glycemia is a glucose level greater than 5.6 mmol/L.
Laboratory tests often include glucose levels, lipid profiles, and blood pressure measurements. Radiologic tests, such as abdominal ultrasound, may be used to rule out other causes of excess weight and metabolic disorders. Differential diagnoses include other conditions such as hypothyroidism, Cushing's syndrome, and various types of diabetes.
Treatment
Treatment of metabolic syndrome requires a comprehensive approach, including lifestyle changes, pharmacological therapy and, in some cases, surgical intervention. The main treatment areas are:
- Lifestyle modifications including a low-carbohydrate, low-fat diet, increased physical activity and weight control.
- Pharmacological treatment aimed at stabilizing blood pressure, reducing glucose levels and correcting the lipid profile.
- Surgical options such as bariatric surgery may be offered to patients with severe obesity.
- Encouraging patients to regularly monitor their condition and support them with either medication or lifestyle changes.
It is important to note that a combination treatment approach not only improves health, but can also significantly reduce the risk of complications.
List of medications used to treat this disease
The main groups of pharmacological agents used to treat metabolic syndrome include:
- Benzene derivatives, such as metformin, to normalize blood glucose levels.
- Statins for lipid control include atorvastatin and rasuvastatin.
- Antihypertensive drugs: ACE inhibitors, beta blockers and diuretics.
- Drugs for the correction of insulin resistance are thiazolidinediones.
- Weight control drugs include sibutramine and orlistat.
These drugs should be prescribed by a physician, depending on the specific indications and the patient's condition.
Disease monitoring
Monitoring metabolic syndrome involves regular checks of key health parameters, such as:
- Measuring weight and waist circumference.
- Control of blood pressure and blood sugar levels.
- Regular testing of blood lipid levels.
- Assessment of general health status and the possibility of further risk reduction.
The prognosis depends on the degree of patient involvement in the treatment process and management of the condition. Without proper control, metabolic syndrome can lead to serious complications, including stroke, myocardial infarction, and chronic kidney disease.
Age-related features of the disease
Metabolic syndrome can manifest itself differently in different age groups. In young people, it is more often associated with genetic predisposition and an unhealthy lifestyle, while in older people, the syndrome often progresses due to concomitant chronic diseases.
- In young people, metabolic syndrome is often caused by obesity due to poor diet and lack of physical activity.
- In middle-aged people, metabolic syndrome often combines stress factors and heavy workloads, which leads to pathological changes in the body.
- In elderly patients, the syndrome manifests itself as a result of the influence of age-related changes on metabolism and may be accompanied by concomitant diseases.
What is important is that each age group requires a specific approach to the treatment and prevention of metabolic syndrome.
Questions and Answers
- What is the main risk of metabolic syndrome? The main risk is an increased likelihood of developing cardiovascular disease and type 2 diabetes, which significantly worsens the patient's quality of life.
- How is metabolic syndrome diagnosed? Diagnosis is made based on the analysis of clinical parameters, including waist circumference, blood pressure level and laboratory test results.
- What are the treatments for metabolic syndrome? Treatment includes lifestyle changes, medication, and in some cases surgery.
- How often should metabolic syndrome be monitored? It is recommended to monitor the condition at least once every 3-6 months, depending on individual risk factors and the general health of the patient.
- Does age affect the severity of metabolic syndrome? Yes, age plays an important role; in young people it is associated with the formation of bad habits, and in older people it is associated with the progression of concomitant diseases.
